Effects of tobacco smoke exposure in childhood on atopic diseases

Current Allergy and Asthma Reports

Volumn 13, Issue 6, 2013, Pages 687-692

  Ciaccio, Christina E ^a,c   Gentile, Deborah ^b  

^a CHILDREN S MERCY HOSPITAL   (United States)

^b ALLEGHENY HEALTH NETWORK   (United States)

^c Division of Allergy Asthma and Immunology   (United States)

Author keywords

Allergic rhinitis; Allergic sensitization; Asthma; Atopic disease; Atopic sensitization; Childhood; Food allergies; IgE sensitization; Nicotine replacement therapies; Secondhand smoke exposure; Smoking cessation; Tobacco smoke

Indexed keywords

AMFEBUTAMONE; NICOTINE GUM; NICOTINE LOZENGE; TOBACCO SMOKE; VARENICLINE;

ARTICLE; ASTHMA; ATOPY; CHILD; CHILDHOOD; DISEASE EXACERBATION; EXPOSURE; HUMAN; IMMUNE SYSTEM; INSOMNIA; NAUSEA; NICOTINE REPLACEMENT THERAPY; PARENT; PUBLIC HEALTH; SENSITIZATION; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; UNITED STATES; XEROSTOMIA;

ASTHMA; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNE SYSTEM; PREVALENCE; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 84890464553     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-013-0389-1     Document Type: Article

References (58)

1. Centers for Disease Control (U.S.). Smoking and health database. Atlanta, Ga.: CDC.
2. United States. Public Health Service. Office of the Surgeon General., United States. Office on Smoking and Health. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Rockville, MD: U.S. Dept. of Health and Human Services, Public Health Service; 2006.
3. Strachan DP, Cook DG. Health effects of passive smoking. 6. Parental smoking and childhood asthma: longitudinal and case-control studies. Thorax. 1998;53:204-12.
4. Cook DG, Strachan DP, Carey IM. Health effects of passive smoking. 9. Parental smoking and spirometric indices in children. Thorax. 1998;53:884-93.
5. Cook DG, Strachan DP. Health effects of passive smoking-10: Summary of effects of parental smoking on the respiratory health of children and implications for research. Thorax. 1999;54:357-66.
6. Strachan DP, Cook DG. Health effects of passive smoking. 4. Parental smoking, middle ear disease and adenotonsillectomy in children. Thorax. 1998;53:50-6.
7. Strachan DP, Cook DG. Health effects of passive smoking.5. Parental smoking and allergic sensitisation in children. Thorax. 1998;53:117-23.
8. Strachan DP, Cook DG. Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax. 1997;52:905-14.
9. Cook DG, Strachan DP. Health effects of passive smoking. 3. Parental smoking and prevalence of respiratory symptoms and asthma in school age children. Thorax. 1997;52:1081-94.
10. Cook DG, Strachan DP, Carey IM. Health effects of passive smoking. Thorax. 1999;54:469.
11. Coultas DB. Health effects of passive smoking. 8. Passive smoking and risk of adult asthma and COPD: an update. Thorax. 1998;53:381-7.
12. White C. Research on smoking and lung cancer: a landmark in the history of chronic disease epidemiology. Yale J Biol Med. 1990;63:29-46.
13. Allwright S, Paul G, Greiner B, et al. Legislation for smoke-free workplaces and health of bar workers in Ireland: before and after study. BMJ. 2005;331:1117.
14. Stallings-Smith S, Zeka A, Goodman P, Kabir Z, Clancy L. Reductions in Cardiovascular, Cerebrovascular, and Respiratory Mortality following the National Irish Smoking Ban: Interrupted Time-Series Analysis. PLoS One. 2013;8:e62063.
15. Kabir Z, Daly S, Clarke V, Keogan S, Clancy L. Smoking ban and small-for-gestational age births in Ireland. PLoS One. 2013;8:e57441.
16. Mackay D, Haw S, Ayres JG, Fischbacher C, Pell JP. Smoke-free legislation and hospitalizations for childhood asthma. N Engl J Med 2010;363:1139-45. This important work demonstrates the power of well composed legislation in the prevention of childhood disease.
17. Matt GE, Quintana PJ, Zakarian JM, et al. When smokers move out and non-smokers move in: residential thirdhand smoke pollution and exposure. Tob Control. 2011;20:e1.
18. Johansson A, Halling A, Hermansson G. Indoor and outdoor smoking: impact on children's health. Eur J Public Health. 2003;13:61-6.
19. Sleiman M, Destaillats H, Smith JD, et al. Secondary organic aerosol formation from ozone-initiated reactions with nicotine and secondhand tobacco smoke. Atmos Environ. 2010;44:4191-8.
20. • Hang B, Sarker AH, Havel C, et al. Thirdhand smoke causes DNA damage in human cells. Mutagenesis 2013;28:381-91. This paper highlights the signficance of health effects of third hand tobacco smoke, an important, newly recognized asthma trigger in children.
21. Shah ZH, Rao S, Mayo HG, Fashner J. Clinical inquiries. What are the most effective ways you can help patients stop smoking? J Fam Pract. 2008;57:478-9.
22. Talhout R, Schulz T, Florek E, van Benthem J, Wester P, Opperhuizen A. Hazardous compounds in tobacco smoke. Int J Environ Res Public Health. 2011;8:613-28.
23. Dye JA, Adler KB. Effects of cigarette smoke on epithelial cells of the respiratory tract. Thorax. 1994;49:825-34.
24. Gangl K, Reininger R, Bernhard D, et al. Cigarette smoke facilitates allergen penetration across respiratory epithelium. Allergy. 2009;64:398-405.
25. • Smelter DF, Sathish V, Thompson MA, Pabelick CM, Vassallo R, Prakash YS. Thymic stromal lymphopoietin in cigarette smoke-exposed human airway smooth muscle. J Immunol 2010;185:3035-40. This paper offers one possible mechanism for the previously recognized association of tobacco smoke and allergic sensitization.
26. Nakamura Y, Miyata M, Ohba T, et al. Cigarette smoke extract induces thymic stromal lymphopoietin expression, leading to T(H)2-type immune responses and airway inflammation. J Allergy Clin Immunol. 2008;122:1208-14.
27. Wilken L, Corbridge SJ. Smoking cessation-part III: Pharmacotherapy of smoking cessation. AAOHN J: Off J Am Assoc Occup Health Nurses. 2005;53:340-4.
28. Ziegler SF, Liu YJ. Thymic stromal lymphopoietin in normal and pathogenic T cell development and function. Nat Immunol. 2006;7:709-14.
29. Stampfli MR, Anderson GP. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol. 2009;9:377-84.
30. Mian MF, Lauzon NM, Stampfli MR, Mossman KL, Ashkar AA. Impairment of human NK cell cytotoxic activity and cytokine release by cigarette smoke. J Leukoc Biol. 2008;83:774-84.
31. Wang L, Joad JP, Zhong C, Pinkerton KE. Effects of environmental tobacco smoke exposure on pulmonary immune response in infant monkeys. J Allergy Clin Immunol. 2008;122:400-6. 6 e1-5.
32. Yu M, Zheng X, Peake J, Joad JP, Pinkerton KE. Perinatal environmental tobacco smoke exposure alters the immune response and airway innervation in infant primates. J Allergy Clin Immunol. 2008;122:640-7 e1.
33. Gyllen P, Andersson BA, Qvarfordt I. Smokeless tobacco or nicotine replacement therapy has no effect on serum immunoglobulin levels. Respir Med. 2004;98:108-14.
34. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. The Cochrane database of systematic reviews 2007:CD000031.
35. Chilmonczyk BA, Salmun LM, Megathlin KN, et al. Association between exposure to environmental tobacco smoke and exacerbations of asthma in children. N Engl J Med. 1993;328:1665-9.
36. McCarville M, Sohn MW, Oh E, Weiss K, Gupta R. Environmental tobacco smoke and asthma exacerbations and severity: the difference between measured and reported exposure. Arch Dis Child. 2013;98:510-4.
37. Comhair SA, Gaston BM, Ricci KS, et al. Detrimental effects of environmental tobacco smoke in relation to asthma severity. PLoS One. 2011;6:e18574.
38. Millett C, Lee JT, Laverty AA, Glantz SA, Majeed A. Hospital admissions for childhood asthma after smoke-free legislation in England. Pediatrics. 2013;131:e495-501.
39. Hanrahan JP, Tager IB, Segal MR, et al. The effect of maternal smoking during pregnancy on early infant lung function. Am Rev Respir Dis. 1992;145:1129-35.
40. Jaakkola JJ, Gissler M. Maternal smoking in pregnancy, fetal development, and childhood asthma. Am J Public Health. 2004;94:136-40.
41. Alati R, Al Mamun A, O'Callaghan M, Najman JM, Williams GM. In utero and postnatal maternal smoking and asthma in adolescence. Epidemiology. 2006;17:138-44.
42. Rumold R, Jyrala M, Diaz-Sanchez D. Secondhand smoke induces allergic sensitization in mice. J Immunol. 2001;167:4765-70.
43. Kulig M, Luck W, Lau S, et al. Effect of pre- and postnatal tobacco smoke exposure on specific sensitization to food and inhalant allergens during the first 3 years of life. Multicenter Allergy Study Group, Germany. Allergy. 1999;54:220-8.
44. Lannero E, Wickman M, van Hage M, Bergstrom A, Pershagen G, Nordvall L. Exposure to environmental tobacco smoke and sensitisation in children. Thorax. 2008;63:172-6.
45. Clinical Practice Guideline Treating Tobacco U. Dependence Update Panel L, Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med. 2008;35:158-76.
46. Centers for Disease C, Prevention. State-specific prevalence and trends in adult cigarette smoking - United States, 1998-2007. MMWR Morbidity and mortality weekly report 2009;58:221-6.
47. Steinberg MB, Delnevo CD. Physician beliefs regarding effectiveness of tobacco dependence treatments: results from the NJ Health Care Provider Tobacco Survey. J Gen Intern Med. 2007;22:1459-62.
48. Kreuter MW, Chheda SG, Bull FC. How does physician advice influence patient behavior? Evidence for a priming effect. Arch Fam Med. 2000;9:426-33.
49. Conroy MB, Majchrzak NE, Regan S, Silverman CB, Schneider LI, Rigotti NA. The association between patient-reported receipt of tobacco intervention at a primary care visit and smokers' satisfaction with their health care. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco 2005;7 Suppl 1:S29-34.
50. Eisenberg MJ, Filion KB, Yavin D, et al. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne 2008;179:135-44.
51. Schnoll RA, Lerman C. Current and emerging pharmacotherapies for treating tobacco dependence. Expert Opin Emerg Drugs. 2006;11:429-44.
52. Lerman C, Kaufmann V, Rukstalis M, et al. Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial. Ann Intern Med. 2004;140:426-33.
53. Karam-Hage M, Cinciripini PM. Pharmacotherapy for tobacco cessation: nicotine agonists, antagonists, and partial agonists. Curr Oncol Rep. 2007;9:509-16.
54. Demazieres A, Luthringer R, Coppel E, et al. Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers. Addict Behav. 2006;31:537-43.
55. Tonstad S, Johnston JA. Does bupropion have advantages over other medical therapies in the cessation of smoking? Expert Opin Pharmacother. 2004;5:727-34.
56. Issa JS, Perez GH, Diament J, Zavattieri AG, de Oliveira KU. Effectiveness of sustained-release bupropion in the treatment of smoker patients with cardiovascular disease. Arq Bras Cardiol. 2007;88:434-40.
57. Niaura R, Hays JT, Jorenby DE, et al. The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial. Curr Med Res Opin. 2008;24:1931-41.
58. Zierler-Brown SL, Kyle JA. Oral varenicline for smoking cessation. Ann Pharmacother. 2007;41:95-9.